0001209191-21-069130.txt : 20211210 0001209191-21-069130.hdr.sgml : 20211210 20211210192000 ACCESSION NUMBER: 0001209191-21-069130 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211208 FILED AS OF DATE: 20211210 DATE AS OF CHANGE: 20211210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SULIMAN SHEHNAAZ CENTRAL INDEX KEY: 0001713070 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38792 FILM NUMBER: 211486640 MAIL ADDRESS: STREET 1: 901 GATEWAY BLVD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alector, Inc. CENTRAL INDEX KEY: 0001653087 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 822933343 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 131 OYSTER POINT BLVD., SUITE 600 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 415-231-5660 MAIL ADDRESS: STREET 1: 131 OYSTER POINT BLVD., SUITE 600 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: Alector LLC DATE OF NAME CHANGE: 20150915 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-12-08 0 0001653087 Alector, Inc. ALEC 0001713070 SULIMAN SHEHNAAZ C/O ALECTOR, INC. 131 OYSTER POINT BLVD, SUITE 600 SOUTH SAN FRANCISCO CA 94080 0 1 0 0 President and COO Common Stock 2021-12-08 4 M 0 19813 17.23 A 122411 D Common Stock 2021-12-08 4 M 0 55187 10.24 A 177598 D Common Stock 2021-12-08 4 S 0 36511 22.5583 D 141087 D Common Stock 2021-12-08 4 S 0 38489 23.0115 D 102598 D Common Stock 2021-12-09 4 M 0 75000 17.23 A 177598 D Common Stock 2021-12-09 4 S 0 72357 22.8034 D 105241 D Common Stock 2021-12-09 4 S 0 2643 23.4043 D 102598 D Employee Stock Option (right to buy) 17.23 2021-12-08 4 M 0 19813 0.00 D 2029-12-31 Common Stock 19813 530187 D Employee Stock Option (right to buy) 10.24 2021-12-08 4 M 0 55187 0.00 D 2030-09-30 Common Stock 55187 134026 D Employee Stock Option (right to buy) 17.23 2021-12-09 4 M 0 75000 0.00 D 2029-12-31 Common Stock 75000 455187 D Includes 755 shares acquired on December 1, 2020 and 1,843 shares acquired on June 1, 2021 pursuant to the Issuer's employee stock purchase plan. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.94 to $22.92, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (6) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.94 to $23.10, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.36 to $23.35, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.36 to $23.44, inclusive. One-fourth of the shares subject to the option grant vested on December 9, 2020, and 1/48th vest monthly thereafter. The shares subject to the option vest in 48 equal monthly installments beginning on November 1, 2020. /s/ David Oh, by power of attorney 2021-12-10